Permanent skin replacement using engineered epidermis containing fewer than 5% syngeneic keratinocytes

Area of Science:

• Regenerative Medicine
• Immunology
• Dermatology

Background:

• Permanent skin replacement is crucial for treating severe skin injuries.
• Heterologous skin grafts offer a potential solution but face immune rejection challenges.
• Optimizing the syngeneic-allogeneic keratinocyte ratio is key to graft success.

Purpose of the Study:

• To investigate the efficacy of heterologous epidermal substitutes with low syngeneic keratinocyte content for permanent skin replacement.
• To evaluate the immune response and tissue regeneration following transplantation of these engineered skin grafts.
• To determine the minimal syngeneic keratinocyte percentage required for successful skin regeneration.

Main Methods:

• Keratinocytes from Balb/c and C3H/HeN mice were co-cultured in varying ratios (e.g., 2% syngeneic-98% allogeneic).
• Graftable epidermal substitutes were generated and transplanted onto recipient mice.
• Graft take, tissue structure, vascularization, and leukocyte infiltration (CD8+, CD4+ lymphocytes) were assessed at 15 and 30 days post-transplantation.

Main Results:

• All heterografts achieved significant graft take (>75%) and skin replacement.
• Regenerated tissues were well-structured, vascularized, and composed solely of syngeneic keratinocytes.
• Leukocyte infiltration was observed but was lower than in allografts, even with 2% syngeneic keratinocytes, indicating moderate immune activation.

Conclusions:

• Functional skin regeneration is achievable using heterologous epidermal substitutes with minimal syngeneic keratinocyte content (as low as 2%).
• These engineered skin grafts promote successful skin replacement with reduced immune responses compared to traditional allografts.
• The findings support the potential of low-syngeneic content heterografts for permanent skin replacement therapies.